health
WHO pushes to expand hydroxyurea access for children with sickle cell disease
WHO has linked new clinical guidance, paediatric formulation priorities and medicine-access work to expand diagnosis and treatment for children and adolescents with sickle cell disease, especially in high-burden countries.